PL1636192T3 - Związki heteroarylowe podstawione grupą 3-alkilidenohydrazynową jako aktywatory receptora trombopoetyny - Google Patents
Związki heteroarylowe podstawione grupą 3-alkilidenohydrazynową jako aktywatory receptora trombopoetynyInfo
- Publication number
- PL1636192T3 PL1636192T3 PL04736117T PL04736117T PL1636192T3 PL 1636192 T3 PL1636192 T3 PL 1636192T3 PL 04736117 T PL04736117 T PL 04736117T PL 04736117 T PL04736117 T PL 04736117T PL 1636192 T3 PL1636192 T3 PL 1636192T3
- Authority
- PL
- Poland
- Prior art keywords
- alkylidenehydrazino
- substituted heteroaryl
- heteroaryl compounds
- thrombopoietin receptor
- receptor activators
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/32—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003161987 | 2003-06-06 | ||
JP2003330627 | 2003-09-22 | ||
JP2003404635 | 2003-12-03 | ||
JP2004094931 | 2004-03-29 | ||
PCT/JP2004/008165 WO2004108683A1 (en) | 2003-06-06 | 2004-06-04 | 3-alkylidenehydrazino substituted heteroaryl compounds as thrombopoietin receptor activators |
EP04736117.5A EP1636192B9 (en) | 2003-06-06 | 2004-06-04 | 3-alkylidenehydrazino substituted heteroaryl compounds as thrombopoietin receptor activators |
Publications (1)
Publication Number | Publication Date |
---|---|
PL1636192T3 true PL1636192T3 (pl) | 2014-05-30 |
Family
ID=33514809
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL04736117T PL1636192T3 (pl) | 2003-06-06 | 2004-06-04 | Związki heteroarylowe podstawione grupą 3-alkilidenohydrazynową jako aktywatory receptora trombopoetyny |
Country Status (18)
Country | Link |
---|---|
US (5) | US7351841B2 (pl) |
EP (1) | EP1636192B9 (pl) |
JP (2) | JP4386072B2 (pl) |
KR (1) | KR101211975B1 (pl) |
AU (1) | AU2004245401B2 (pl) |
CA (1) | CA2520115C (pl) |
DK (1) | DK1636192T3 (pl) |
ES (1) | ES2445029T3 (pl) |
HK (1) | HK1091809A1 (pl) |
IL (1) | IL172374A (pl) |
MX (1) | MXPA05013209A (pl) |
NO (1) | NO334084B1 (pl) |
NZ (1) | NZ542495A (pl) |
PL (1) | PL1636192T3 (pl) |
PT (1) | PT1636192E (pl) |
TW (1) | TWI395739B (pl) |
UA (1) | UA82695C2 (pl) |
WO (1) | WO2004108683A1 (pl) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA82695C2 (uk) * | 2003-06-06 | 2008-05-12 | Нисан Кемикал Индастриз, Лтд. | Гетероароматичні сполуки як активатори рецептора тромбопоетину |
FR2866886B1 (fr) * | 2004-02-26 | 2007-08-31 | Sanofi Synthelabo | Derives d'aryl-et d'heteroaryl-akylcarbamates, leur preparation et leur application en therapeutique |
WO2005118551A2 (en) * | 2004-05-28 | 2005-12-15 | Ligand Pharmaceuticals Inc. | Thrombopoietin activity modulating compounds and methods |
AU2005299720B2 (en) * | 2004-10-25 | 2010-02-04 | Ligand Pharmaceuticals Incorporated | Thrombopoietin activity modulating compounds and methods |
TW200633997A (en) * | 2004-12-08 | 2006-10-01 | Nissan Chemical Ind Ltd | Substituted heterocyclic compounds and thrombopoietin receptor activators |
UA89970C2 (ru) * | 2004-12-08 | 2010-03-25 | Ниссан Кемикал Индастрис, Лтд. | Гетероциклические соединения и активаторы рецептора тромбопоэтина |
US8552031B2 (en) * | 2004-12-08 | 2013-10-08 | Nissan Chemical Industries, Ltd. | 3-ethylidenehydrazino substituted heterocyclic compounds as thrombopoietin receptor activators |
TW200633998A (en) * | 2004-12-08 | 2006-10-01 | Nissan Chemical Ind Ltd | Substituted heterocyclic compounds and thrombopoietin receptor activators |
EP1845090A4 (en) * | 2004-12-14 | 2009-11-11 | Nissan Chemical Ind Ltd | AMIDE COMPOUND AND THROMBOPOIETINE RECEPTOR ACTIVATOR |
US7968542B2 (en) | 2005-07-15 | 2011-06-28 | Nissan Chemical Industries, Ltd. | Thiophene compounds and thrombopoietin receptor activators |
JP5104752B2 (ja) * | 2005-07-20 | 2012-12-19 | 日産化学工業株式会社 | ピラゾール化合物及びトロンボポエチンレセプター活性化剤 |
WO2007052808A1 (ja) * | 2005-11-07 | 2007-05-10 | Nissan Chemical Industries, Ltd. | ヒドラジド化合物及びトロンボポエチンレセプター活性化剤 |
WO2007142308A1 (ja) | 2006-06-07 | 2007-12-13 | Nissan Chemical Industries, Ltd. | 含窒素ヘテロ環化合物及びトロンボポエチンレセプター活性化剤 |
US7784330B2 (en) * | 2007-10-05 | 2010-08-31 | Schlumberger Technology Corporation | Viscosity measurement |
US9115341B2 (en) | 2007-12-05 | 2015-08-25 | Nissan Chemical Industries, Ltd. | Method for expanding hematopoietic stem cells using heterocyclic compound |
US20100310535A1 (en) * | 2007-12-05 | 2010-12-09 | Nissan Chemical Industries, Ltd. | Method for expanding hematopoietic stem cells using heterocyclic compound |
EP2228435A4 (en) * | 2007-12-05 | 2013-01-23 | Nissan Chemical Ind Ltd | METHOD FOR AMPLIFYING HEMATOPOIETIC STRAIN CELL USING HETEROCYCLIC COMPOUND |
CA2708050C (en) * | 2007-12-06 | 2016-08-16 | Nissan Chemical Industries, Ltd. | Method for expanding hematopoietic stem cells using heterocyclic compound |
TWI476187B (zh) * | 2008-02-29 | 2015-03-11 | Nissan Chemical Ind Ltd | Thiophene compounds and intermediates thereof |
JP2012521359A (ja) * | 2009-03-20 | 2012-09-13 | アリオス バイオファーマ インク. | 置換されたヌクレオシドアナログおよびヌクレオチドアナログ |
US8680150B2 (en) * | 2009-05-28 | 2014-03-25 | Ligand Pharmaceuticals, Inc. | Small molecule hematopoietic growth factor mimetic compounds that activate hematopoietic growth factor receptors |
WO2010140685A1 (ja) | 2009-06-04 | 2010-12-09 | 日産化学工業株式会社 | ヘテロ環化合物及び造血幹細胞の増幅剤 |
US8889732B2 (en) | 2009-10-23 | 2014-11-18 | Nissan Chemical Industries, Ltd. | Fused heterocyclic compounds and thrombopoietin receptor activators |
CN103209987B (zh) | 2010-09-22 | 2017-06-06 | 艾丽奥斯生物制药有限公司 | 取代的核苷酸类似物 |
JP2012111750A (ja) * | 2010-11-02 | 2012-06-14 | Nissan Chem Ind Ltd | アミノ安息香酸誘導体の溶媒和物及びその製造方法 |
UA109287C2 (uk) | 2010-11-02 | 2015-08-10 | Солі органічного аміну похідних амінобензойної кислоти і спосіб їх одержання | |
US20140227780A1 (en) * | 2011-10-03 | 2014-08-14 | Nissan Chemical Industries, Ltd. | Method for producing megakaryocytes and/or platelets from pluripotent stem cells |
AU2012358804B2 (en) | 2011-12-22 | 2018-04-19 | Alios Biopharma, Inc. | Substituted phosphorothioate nucleotide analogs |
WO2013142124A1 (en) | 2012-03-21 | 2013-09-26 | Vertex Pharmaceuticals Incorporated | Solid forms of a thiophosphoramidate nucleotide prodrug |
EP2827876A4 (en) | 2012-03-22 | 2015-10-28 | Alios Biopharma Inc | PHARMACEUTICAL COMBINATIONS WITH A THIONUCLEOTIDE ANALOG |
CN103664622B (zh) * | 2012-09-18 | 2016-01-13 | 浙江工业大学 | Ab型羟基改性高聚物的单体及其中间体和制备方法 |
JP6279430B2 (ja) * | 2014-08-21 | 2018-02-14 | 東芝メモリ株式会社 | テンプレート、テンプレート形成方法および半導体装置の製造方法 |
CA2966150A1 (en) | 2014-10-31 | 2016-05-06 | Nissan Chemical Industries, Ltd. | Ligand-binding fiber and cell culture substrate using said fiber |
WO2018199797A1 (ru) * | 2017-04-27 | 2018-11-01 | Общество с ограниченной ответственностью "ОнкоТартис" | Замещенные 2-метилиден-5-(фениламино)-2,3-дигидротиофен-3-оны для лечения лейкозов с транслокациями mll-гена и других онкологических заболеваний |
EP3983406A4 (en) * | 2019-06-12 | 2023-09-06 | Ontario Institute for Cancer Research (OICR) | HETEROCYCLOALKYL AND UNSATURATED HETEROAROMATIC ACYLHYDRAZONE LINKERS, RELATED METHODS AND USES |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0258182A1 (en) * | 1986-08-08 | 1988-03-02 | Sandoz Ag | Semicarbazones and thiosemicarbazones |
ZA981934B (en) * | 1997-03-10 | 1999-09-06 | Rhone Poulenc Agrochimie | Pesticidal 1-aryl-3-iminopyrazoles. |
US6270345B1 (en) * | 1999-10-28 | 2001-08-07 | Dove Systems, Inc. | Vane motor for dental and medical handpieces |
AU1462201A (en) | 1999-11-05 | 2001-06-06 | Smithkline Beecham Corporation | Semicarbazone derivatives and their use as thrombopoietin mimetics |
US6720345B1 (en) | 1999-11-05 | 2004-04-13 | Smithkline Beecham Corporation | Semicarbazone derivatives and their use as thrombopoietin mimetics |
CA2436288A1 (en) | 2000-12-19 | 2002-06-27 | Smithkline Beecham Corporation | Thrombopoietin mimetics |
EP1370252A4 (en) * | 2001-03-01 | 2006-04-05 | Smithkline Beecham Corp | Thrombopoietin mimetics |
CA2495184A1 (en) | 2002-08-14 | 2004-02-26 | Nissan Chemical Industries, Ltd. | Thrombopoietin receptor activators and process for their production |
TWI324593B (en) | 2002-10-09 | 2010-05-11 | Nissan Chemical Ind Ltd | Pyrazolone compounds and thrombopoietin receptor activator |
UA82695C2 (uk) | 2003-06-06 | 2008-05-12 | Нисан Кемикал Индастриз, Лтд. | Гетероароматичні сполуки як активатори рецептора тромбопоетину |
US8552031B2 (en) * | 2004-12-08 | 2013-10-08 | Nissan Chemical Industries, Ltd. | 3-ethylidenehydrazino substituted heterocyclic compounds as thrombopoietin receptor activators |
EP1845090A4 (en) | 2004-12-14 | 2009-11-11 | Nissan Chemical Ind Ltd | AMIDE COMPOUND AND THROMBOPOIETINE RECEPTOR ACTIVATOR |
WO2006112413A1 (ja) | 2005-04-14 | 2006-10-26 | Nissan Chemical Industries, Ltd. | α置換ビニルスズ化合物 |
US7968542B2 (en) | 2005-07-15 | 2011-06-28 | Nissan Chemical Industries, Ltd. | Thiophene compounds and thrombopoietin receptor activators |
JP5104752B2 (ja) | 2005-07-20 | 2012-12-19 | 日産化学工業株式会社 | ピラゾール化合物及びトロンボポエチンレセプター活性化剤 |
WO2007142308A1 (ja) | 2006-06-07 | 2007-12-13 | Nissan Chemical Industries, Ltd. | 含窒素ヘテロ環化合物及びトロンボポエチンレセプター活性化剤 |
JP5065974B2 (ja) * | 2008-04-10 | 2012-11-07 | 株式会社船井電機新応用技術研究所 | マイクロホンユニット及びその製造方法 |
-
2004
- 2004-04-06 UA UAA200511618A patent/UA82695C2/uk unknown
- 2004-06-02 TW TW093115872A patent/TWI395739B/zh not_active IP Right Cessation
- 2004-06-04 MX MXPA05013209A patent/MXPA05013209A/es active IP Right Grant
- 2004-06-04 NZ NZ542495A patent/NZ542495A/xx unknown
- 2004-06-04 ES ES04736117.5T patent/ES2445029T3/es not_active Expired - Lifetime
- 2004-06-04 WO PCT/JP2004/008165 patent/WO2004108683A1/en active Application Filing
- 2004-06-04 DK DK04736117.5T patent/DK1636192T3/en active
- 2004-06-04 JP JP2006508502A patent/JP4386072B2/ja not_active Expired - Fee Related
- 2004-06-04 CA CA2520115A patent/CA2520115C/en not_active Expired - Fee Related
- 2004-06-04 PL PL04736117T patent/PL1636192T3/pl unknown
- 2004-06-04 AU AU2004245401A patent/AU2004245401B2/en not_active Ceased
- 2004-06-04 PT PT47361175T patent/PT1636192E/pt unknown
- 2004-06-04 EP EP04736117.5A patent/EP1636192B9/en not_active Expired - Lifetime
-
2005
- 2005-10-21 NO NO20054885A patent/NO334084B1/no not_active IP Right Cessation
- 2005-11-16 KR KR1020057021844A patent/KR101211975B1/ko active IP Right Grant
- 2005-12-05 IL IL172374A patent/IL172374A/en active IP Right Grant
- 2005-12-06 US US11/294,609 patent/US7351841B2/en not_active Expired - Lifetime
-
2006
- 2006-07-19 HK HK06108101.3A patent/HK1091809A1/xx not_active IP Right Cessation
-
2007
- 2007-08-13 US US11/837,659 patent/US7576115B2/en not_active Expired - Lifetime
-
2009
- 2009-06-26 US US12/492,435 patent/US8318796B2/en active Active
- 2009-08-17 JP JP2009188693A patent/JP5099089B2/ja not_active Expired - Fee Related
-
2012
- 2012-09-13 US US13/613,195 patent/US20130012708A1/en not_active Abandoned
-
2013
- 2013-10-28 US US14/064,367 patent/US20140051857A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1091809A1 (en) | 3-alkylidenehydrazino substituted heteroaryl compounds as thrombopoietin receptor activators | |
IL174375A0 (en) | Novel heterocyclic compounds as hsp90-inhibitors | |
IL183647A0 (en) | 3-ethylidenehydrazino substituted heterocyclic compounds as thrombopoietin receptor activators | |
PL376754A1 (pl) | Związki heterocykliczne użyteczne jako aktywatory Nurr-1 | |
GB0304424D0 (en) | Novel compounds | |
EP1596860A4 (en) | NEW CONNECTIONS | |
EP1648885A4 (en) | NEW CONNECTIONS | |
GB0305426D0 (en) | Novel compounds | |
ZA200509643B (en) | 3-alkylidenehydrazino substituted heteroaryl compounds as thrombopoietin receptor activators | |
GB0302431D0 (en) | Novel compounds | |
GB0302546D0 (en) | Novel compounds | |
GB0304809D0 (en) | Novel compounds | |
ZA200704979B (en) | 3-ethylidenehydrazino substituted heterocyclic compounds as thrombopoietin receptor activators | |
EP1635834A4 (en) | NEW COMPOUNDS | |
GB0303467D0 (en) | Novel compounds | |
GB0301589D0 (en) | Novel compounds | |
GB0305293D0 (en) | Novel compounds | |
GB0304408D0 (en) | Novel compounds | |
GB0304803D0 (en) | Novel compounds | |
GB0303464D0 (en) | Novel compounds | |
GB0305163D0 (en) | Novel compounds | |
GB0305165D0 (en) | Novel compounds | |
GB0305285D0 (en) | Novel compounds | |
GB0301955D0 (en) | Novel compounds | |
GB0301872D0 (en) | Novel compounds |